Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa

…, LM Abbo, R Jain, M Nigo… - Clinical Infectious …, 2017 - academic.oup.com
A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas
aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 …

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial

…, S Anjan, R Mathew, B Patel, M Nigo… - JAMA internal …, 2022 - jamanetwork.com
Importance There is clinical equipoise for COVID-19 convalescent plasma (CCP) use in
patients hospitalized with COVID-19. Objective To determine the safety and efficacy of CCP …

Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae

M Nigo, CS Cevallos, K Woods, VM Flores… - Antimicrobial agents …, 2013 - Am Soc Microbiol
We performed a nested case-control study (ratio of 1:4) on the emergence of tigecycline-resistant
multidrug-resistant Klebsiella pneumoniae (TR-MDRKP) isolates among patients who …

[HTML][HTML] Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation …

L Rasmy, M Nigo, BS Kannadath, Z Xie… - The Lancet Digital …, 2022 - thelancet.com
Background Predicting outcomes of patients with COVID-19 at an early stage is crucial for
optimised clinical care and resource management, especially during a pandemic. Although …

Ceftaroline-resistant, daptomycin-tolerant, and heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus causing infective endocarditis

M Nigo, L Diaz, LP Carvajal, TT Tran… - Antimicrobial agents …, 2017 - Am Soc Microbiol
We report a case of infective endocarditis (IE) caused by ceftaroline-resistant, daptomycin-tolerant,
and heterogeneous vancomycin-intermediate methicillin-resistant S. aureus (MRSA). …

What's new in the treatment of enterococcal endocarditis?

M Nigo, JM Munita, CA Arias, BE Murray - Current infectious disease …, 2014 - Springer
Enterococcus spp. are among the common pathogens causing infective endocarditis (IE).
Despite major medical advances and new potent antimicrobial agents, the mortality has not …

[HTML][HTML] Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis

…, Z Temesgen, AG Theofiles, M Nigo… - The Journal of …, 2022 - Am Soc Clin Investig
Subcutaneous phaeohyphomycosis typically affects immunocompetent individuals following
traumatic inoculation. Severe or disseminated infection can occur in CARD9 deficiency or …

[HTML][HTML] PK-RNN-V E: A deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data

M Nigo, HTN Tran, Z Xie, H Feng, B Mao… - Journal of Biomedical …, 2022 - Elsevier
Vancomycin is a commonly used antimicrobial in hospitals, and therapeutic drug monitoring
(TDM) is required to optimize its efficacy and avoid toxicities. Bayesian models are currently …

Long-term Use of Tedizolid as Suppressive Therapy for Recurrent Methicillin-Resistant Staphylococcus aureus Graft Infection

M Nigo, AM Luce, CA Arias - Clinical Infectious Diseases, 2018 - academic.oup.com
Staphylococcus aureus (MRSA) infection of an infected endovascular graft. The patient is a
69 year-old man with a history of severe peripheral vascular disease who underwent right to …

Two Cases of Fatal Hyperammonemia Syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients Outside Lung …

…, A De Golovine, JS Bynon, M Nigo - Open forum …, 2019 - academic.oup.com
DISCUSSION We described two cases of HS caused by M hominis and Ureaplasma spp. in
immunocompromised patients. An additional case due to U parvum was recently reported in …